Canada becomes the first G7 country to approve a generic version of semaglutide(canada.ca)
canada.ca
Canada becomes the first G7 country to approve a generic version of semaglutide
https://www.canada.ca/en/health-canada/news/2026/04/canada-becomes-the-first-g7-country-to-approve-a-generic-version-of-semaglutide.html
The conspiracy theory version of how Novo allowed its patent to lapse is that in the absence of a patent, a certain Canadian Patented Medicine Price Review Board did not have jurisdiction to investigate Novo's drugs for being overpriced, so Novo could keep charging its exorbitant prices.